- Novel Coronavirus
-
Drug Discovery Services
- Antiviral Drug Discovery
- Complement Therapy
- SARS-CoV-2 Aptamers
- Antisense Oligonucleotides
- Protease Inhibitors
- Inhibitor of Host Cell Protease
- Abelson Kinase Inhibitors
- RNA Synthesis Inhibitors
- Nucleoside Analogue
- Neuraminidase Inhibitors
- Neutralizing Antibody
- Antiviral Peptide
- Broad-spectrum Antiviral Drug
- Anti-Inflammatory Drugs
- High-Throughput Screening
- Vaccine Discovery
- Evaluation Platforms for SARS-CoV-2 Drugs
- Antiviral Drug Discovery
- IVD Immunoassays
- Products
- Resources
- About Us
Lopinavir (CAT#: Vinh-Wyb001)
| CAT | Size | Price | Quantity | |
|---|---|---|---|---|
| Vinh-Wyb001 |
|
For Research Use Only. We do not provide direct services or products for patients.
- Product Overview
- Molecular Formula: C37H48N4O5; Molecular Weight: 628.8 g.mol-1
- CAS No.
- 192725-17-0
- Target
- SARS-CoV-2
- Molecular Formula
- C37H48N4O5
- Molecular Weight
- 628.8 g.mol-1
- Purity
- >98%
- Introduction
- Lopinavir is a potent HIV protease inhibitor with a Ki of 1.3pM. Lopinavir can block the division of Gag-Pol polyprotein, resulting in the production of immature, non-infectious virus particles. In vitro antiviral activity experiments showed that lopinavir showed in vitro antiviral activity against laboratory HIV and clinical HIV isolates in acutely infected lymphoblastoid cell lines and peripheral blood lymphocytes. In addition, lopinavir has a preventive effect on cervical cancer caused by human papillomavirus (HPV).
Online Inquiry
For Research Use Only. We do not provide direct services or products for patients.
For Research Use Only. We do not provide direct services or products for patients.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.